RETATRUTIDE 32MG
What the Retatrutide 32 mg Pen Noventra is
A multi-dose injectable pen containing 32 mg of retatrutide peptide.
Used in weekly subcutaneous injections (under the skin).
Designed to support weight loss and metabolic health.
It works by activating three hormone receptors:
GLP-1 – reduces appetite and slows stomach emptying.
GIP – improves insulin response and satiety.
Glucagon receptor – increases fat burning and energy expenditure.
Because it targets three pathways, studies show it may produce very large weight-loss results (up to ~24% body weight in trials).
Typical dosing schedule (example protocol)
Many 32 mg pens are used like this:
| Weeks | Dose per week |
|---|---|
| 1–4 | 2 mg |
| 5–8 | 4 mg |
| 9–12 | 6 mg |
| 13+ | up to 8 mg weekly |
This gradual increase helps reduce side effects.
Important safety facts
Inject once per week (abdomen, thigh, or arm).
Store in the fridge (2–8 °C) before use.
Use under medical supervision.
Possible side effects:
nausea
constipation
fatigue
headache
⚠️ Also important:
Retatrutide is still considered investigational and not widely approved yet, so many products sold online are research peptides.
✅ Summary:
The Retatrutide 32 mg Naventra pen is a weekly injectable peptide for weight loss, working on GLP-1, GIP, and glucagon receptors to reduce appetite, improve insulin control, and increase fat burning.
